Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim

Last Updated: December 5, 2021

DrugPatentWatch Database Preview

Patent: 6,552,181

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,552,181
Title: Basal cell carcinoma tumor supressor gene
Abstract:This invention provides for a tumor suppressor gene inactivation of which is a causal factor in nevoid basal cell carcinoma syndrome and various sporadic basal cell carcinomas. The NBCCS gene is a homologue of the Drosophila patched (ptc) gene.
Inventor(s): Dean; Michael Carlton (Frederick, MD), Hahn; Heidi Eve (Washington, DC), Wicking; Carol (Auchenflower, AU), Christiansen; Jeffrey (Yeronga, AU), Zaphiropoulos; Peter G (Tullinge, SE), Gailani; Mae R. (Guilford, CT), Shanley; Susan Mary (Norman Park, AU), Chidambaram; Abirami (Frederick, MD), Vorechovsky; Igor (Huddinge, SE), Holmberg-Lindstrom; Erika (Solna, SE), Unden; Anne Birgitte (Huddinge, SE), Gillies; Susan Alana (Newfarm, AU), Negus; Kylie (Queenslopes, AU), Smyth; Ian Mcleod (Fig Tree Pocket, AU), Pressman; Carol Leah (Houston, TX), Leffell; David J. (New Haven, CT), Gerrard; Bernard (Frederick, MD), Goldstein; Alisa Miriam (Rockville, MD), Wainwright; Brandon (Bardon, AU), Toftgard; Rune Carl-Magnus (Skarholmen, SE), Chenevix-Trench; Georgia (Toowong, AU), Bale; Allen E. (Northford, CT)
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
Application Number:08/857,636
Patent Claims:see list of patent claims

Details for Patent 6,552,181

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 1986-06-04 ⤷  Try it Free 2016-05-17
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try it Free 2016-05-17
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.